SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1878 5492 OR L773:0966 3274
 

Sökning: L773:1878 5492 OR L773:0966 3274 > (2010-2014) > Imaging the in vivo...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002783naa a2200361 4500
001oai:DiVA.org:uu-216763
003SwePub
008140124s2013 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2167632 URI
024a https://doi.org/10.1016/j.trim.2013.09.0092 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Berglund, Davidu Uppsala universitet,Klinisk immunologi,Transplantationskirurgi4 aut0 (Swepub:uu)davbe892
2451 0a Imaging the in vivo fate of human T cells following transplantation in immunoincompetent mice - Implications for clinical cell therapy trials
264 1b Elsevier BV,c 2013
338 a print2 rdacarrier
520 a Many forms of adoptive T cell therapy are on the verge of being translated to the clinic. To gain further insight in their immunomodulating functions and to optimize future clinical trials it is essential to develop techniques to study their homing capacity. CD4+ T cells were labeled using [In-111]oxine, and the radioactive uptake was determined in vitro before intravenous injection in immunodeficient mice. In vivo biodistribution of [In-111] oxine-labeled cells or tracer alone was subsequently measured by mu SPECT/CT and organ distribution. CD4+ T cells incorporated [In-111]oxine with higher labeling yield using Ringer-Acetate compared to 0.9% NaCl. Cellular viability after labeling with [In-111]oxine was not compromised using less than 0.4 MBq/million cells. After intravenous infusion CD4+ T cells preferentially homed to the liver (p < 0.01) and spleen (p < 0.05). This study presents a protocol for labeling of T cells by [In-111]oxine with preserved viability and in vivo tracking by SPECT for up to 8 days, which can easily be translated to clinical cell therapy trials. 
653 a T cell
653 a In vivo imaging
653 a Cell therapy
653 a SPECT/CT
700a Karlsson, Marieu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)makar254
700a Palanisamy, Senthilkumaru Uppsala universitet,Plattformen för preklinisk PET4 aut
700a Carlsson, Björnu Uppsala universitet,Klinisk immunologi4 aut
700a Korsgren, Olleu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ollekors
700a Eriksson, Olofu Uppsala universitet,Plattformen för preklinisk PET4 aut0 (Swepub:uu)oloer586
710a Uppsala universitetb Klinisk immunologi4 org
773t Transplant Immunologyd : Elsevier BVg 29:1-4, s. 105-108q 29:1-4<105-108x 0966-3274x 1878-5492
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-216763
8564 8u https://doi.org/10.1016/j.trim.2013.09.009

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy